Olix USA Inc.

About Olix USA Inc.

Olix USA Inc. is a San Diego-based biotechnology company that develops RNA interference therapeutics for ocular and central nervous system diseases. Founded in 2010, the company leverages asymmetric siRNA technology to silence disease-causing genes in conditions such as glaucoma, age-related macular degeneration, and Huntington's disease. Its lead candidate, OLX10010, is in Phase 1 trials for glaucoma, while other programs target wet AMD and Huntington's disease. Olix partners with pharmaceutical companies to advance its pipeline and maintain operations across the United States and South Korea.